| Literature DB >> 33885030 |
Akshay R Date1, Yan Mei Goh2, Yan Li Goh3, Ilayaraja Rajendran4, Ravindra S Date5.
Abstract
BACKGROUND: Elective surgery is the treatment of choice for symptomatic giant hiatus hernia (GHH), and quality of life (QoL) has become an important outcome measure following surgery. The aim of this study is to review the literature assessing QoL following repair of GHH.Entities:
Keywords: Giant hiatus hernia; quality of life; surgical repair
Year: 2021 PMID: 33885030 PMCID: PMC8486064 DOI: 10.4103/jmas.JMAS_233_20
Source DB: PubMed Journal: J Minim Access Surg ISSN: 1998-3921 Impact factor: 1.407
Figure 1PRISMA chart
Included studies and study characteristics
| Authors | Study type | Prospective/retrospective | Definition of hernia in the study | Total number of patients | Number of patients followed up | Length of follow-up (months) | Recurrence (symptomatic) | Recurrence endoscopic (E) or radiological (R) (%) | Mean age in years | Types of surgery | Mortality | Questionnaire used |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asti | Case series | Retrospective | Type III and >5 cm | 84 | 75 | 24 | n/a | 12E (4 mesh, 8 no mesh) | 65 | NF or Toupe and mesh versus no mesh | 0 | GERD-HRQL |
| Chen | Case series | Retrospective | >50% | 69 | 54 | 114 | n/a | 12 (34) R | 66 | Dor, 270F, NF +mesh | n/a | GIQLI |
| Dallemagne | Case series | Retrospective | >50%, Type II or III, Type IV | 85 | 64 | 118 | 2 (3%) redo | 23 (66) R | 66 | NF, Toupe CR, CR with pledgets, mesh, emergency | 0 | GIQLI |
| Ferri | Prospective | PEH | 60 | 23 (78% open) 34 (91% lap) | 45 | n/a | 8 (44 open) 7 (31 lap) | n/a | emergency, open, lap, NF gastrostomy, GP | n/a | GERD-HRQL; SF-12 | |
| Furtado | Case series | Retrospective | >50% | 100 | 85 | 27 | n/a | 24 (24%) R | 71 | NF + CR | 1 | GIQLI; Visick; DSS |
| Gibson | Case series | Retrospective | >30%, 10% Type IV | 100 | 92 | 24 | 9 (9%) 2 redo and 7 dilatation | 7 (7) R, 2 (2) redo | 69.1 | NF, GP | 0 | GIQLI; Visick |
| Hall | Case series | Retrospective | PEH II, III, IV | 314 | 188 | 24 | n/a | n/a | 69.1 | NF versus Toupe | 1 | GERD-HRQL; RSI; DSS; SF-36 |
| Hazebroek | Case series | Retrospective | PEH | 40 | 37 | 12 | n/a | 1 R | 65.2 | CR, 270F over 56 Fr Bougie+mesh | 0 | QOLRAD |
| Hazebroek | Case series | Retrospective | PEH Type II or III | 35 | 30 | 43 | 1 | 0 | 77 | CR, 270F | 0 | QOLRAD |
| Huerta | Case series | Retrospective | PEH Type III and IV | 179 | 77 | 54 (Nissen); 25 (Toupet) | n/a | 5 (4) NF, 2 (3) T (R and symptomatic) | 64 | NF versus Toupe | n/a | GERD-HRQL |
| Ilyashenko | Case series | Retrospective | PEH Type III | 98 | 95 | 48 | 5 non-mesh; 2 redo | 1 mesh, 8 no mesh | 63 | Mesh versus no mesh, anterior CR | 0 | GERD-HRQL |
| Kang | Case series | Prospective | >1/3rd of the stomach | 89 | 29 | 69.7 | 1 re do | 6 (6.7) E or R | 62.7 | CR, mesh | n/a | QLSGR |
| Karmali | Case series | Retrospective | >1/3rd of the stomach | 93 | 71 | 17 lap 21 open | 3 redo (2 lap, 1 open) | 4 (9) lap 4 (9) open | 64 Lap 72 open | Lap versus open, NF, 180F 270F, CG, PEG | 0 | GERD-HRQL |
| Koetje | Randomised controlled trial | Prospective | Large hiatus hernia >50% | 126 | 105 | 24 | 9 | 29 | 68 | CR versus non-absorbable mesh versus absorbable mesh | 1 | SF-36 |
| Laan | Case series | Retrospective | >50% | 236 | 193 | 120 | 5 NF; 3 BM IV | NF12 R 9 E BMIV 9 R 8 E | 71 | NF versus BMIV, CG | 1 | GERD-HRQL |
| Lidor | Case series | Prospective | PEH Type III | 111 | 89 | 36 | 1 | 19 (27) R | 61 | NF and mesh±GP | 0 | n/a |
| Louie | Case series | Retrospective | PEH Type II | 58 | 55 | 15 | n/a | 6 (10) or R | 78 | NF, Hill, NF + Hill, mesh, emergency | 0 | GERD-HRQL; QOLRAD |
| Marano | Case series | Prospective | PEH | 13 | 13 | 12 | 0 | 0 | 67 | CR and NF, mesh | 0 | GERD-HRQL; SF-36 |
| Merzilikin | Case series | Retrospective | PEH | 59 | 38 | 60 | n/a | 5 | 74 | NF with 56-60 Fr bougie or Hill with 43 bougie or NF-Hill | 2 | GERD-HRQL; QOLRAD; DSS |
| Ng | Case series | Prospective | n/a | 28 | 28 | 6 | n/a | n/a | 70.83 (bougie), 62.29 (non-bougie) | 270F bougie versus no bougie | 0 | QOLRAD |
| Oelschlager | Randomised controlled trial | Prospective | PEH | 108 | 72 | 58 | 0 in mesh, 2 (3.5) in non-mesh | 20 (59) no mesh 14 (54) mesh | 64 | Mesh versus no mesh | 0 | SF-36 |
| Parameswaran | Case series | Retrospective | PEH >50% of the stomach into the chest | 49 | 31 | 19 | 4 (12.9) | 4 (14.8) R | 68 | NF, GP, CG, emergency | 0 | GERD-HRQL; GSRS |
| Parker | Case series | Retrospective | PEH Type III, IV | 267 | n/a | 15.8 | 3 (1.1) | 6 (4.3) | 58 (<69 y) | NF, Dor, CG, mesh, emergency | 1 | QOLRAD |
| Pierre | Case series | Retrospective | >1/3rd of the stomach | 203 | 152 | 18 | 2 re do | 4 | 67 | NF, CG+NF,180 F.CG+180F, Roux-enY | 1 | GERD-HRQL |
| Qureshi | Case series | Prospective | Giant PEH | 21 | 14 | 13 | 0 | 2 R and E | n/a | NF, Hill | 0 | GERD-HRQL; QOLRAD; DSS |
| Shreshtha | Case series | Retrospective | >5 cm or 30% | 60 | 60 | 60 | 5 (8) | 4 (7) | 71 | NF and GP, emergency | 2 | GERD-HRQL |
| Siboni | Case series | Retrospective | >50%, PEH Type III or IV | 49 | 37 | 24 | 0 | 2 (5.4) E and R | 61 | CR and Toupe | n/a | GERD-HRQL; SF-36 |
| Stiven | Case series | Prospective | PEH | 114 | 94 | 12 | n/a | n/a | 67 | CR+ 180F with bougie | 1 | QOLRAD |
| Stringham | Case series | Prospective | >30% | 106 | 101 | 12 | 37 (36.6) | 33 (32.7) R | 68 | Lap open NF, BMIV | 1 | GERD-HRQL |
| Tam | Case series | Retrospective | PEH >30% | 795 | 606 | 25 | Redo mesh 9 (9), non-mesh 21 (3) | mesh 15 (22), non-mesh 86 (17) | >70, <70 | CR, mesh, CG | 14 (1.8%) from Nason, 2011 | GERD-HRQL; SF-36 |
| Taragona | Case series | Retrospective | PEH <50% (39), >50% (31), 100 (7%) | 77 | 37 | 108 | 12 (22) | R 20 (46) | 64 | NF | 1 | GIQLI |
| Velanovich | Case series | Prospective | Type II and III PEH | 44 | 39 | 24 | 3 | n/a | 66 | CR+GP. BMIV, lap or open NF/Toupe, CG-NF, open repair with gastrectomy, emergency | 1 | SF-36 |
| Wang | Case series | Retrospective | PEH | 65 | 65 | 25 mesh; 43 no mesh | n/a | no mesh 12 (37.5), mesh 8 (24.2) | 65 | Mesh versus no mesh, lap open, thoracotomy, recurrent hernias | n/a | GERD-HRQL; SF-36 |
| Whitson | Case series | Retrospective | GHH | 61 | 52 | 24 | 0 | 2 (4.7) | 62 | CG-NF, NF | 1 | GERD-HRQL |
| Zahiri | Case series | Retrospective | PEH | 317 | 167 | 12 | 2 | n/a | 64.6 NF; 60.2 Toupe | Nissen, Toupet | 0 | GERD-HRQL |
| Zehetner | Case series | Retrospective | PEH >50% | 35 | 23 | 14 | 1 | 2 | 70 | NF | 0 | GERD-HRQL |
| Zhu | Case series | Prospective | PEH >50% | 30 | 30 | 24 | 0 | 5 (17) R | 70 | NF | 0 | GIQLI |
| Zugel | Case series | Prospective | Large PEH | 26 | 20 | 24 | 0 | 0 mesh; 3 non-mesh | 70 | CR, NF, mesh | 0 | GIQLI |
PEH: Paraoesophageal hernia, Lap: Laparoscopic, O: Open; NF: Nissen fundoplication, BM IV: Belsey Mark IV, CR: Crural repair, PEG: Percutaneous gastrostomy, Fr: French, GP: Gastropexy, CG: Collis gastroplasty, 270F: 270° posterior fundoplication, GERD-HRQL: Gastro-Oesophageal Reflux Disease-Health-Related Quality of Life, QOLRAD: Quality of Life in Reflux and Dyspepsia, QOL: Quality of life, GIQLI: Gastrointestinal Quality of Life Index, SF: Short Form health surveys, GSRS: Gastrointestinal Symptom Rating Scale, DSS: Dysphagia Severity Scale, n/a: Not available, y: Years, RSI: Reflux severity index; QLSGR: Quality of life scale for gastroesophageal reflux disease to key please
Description of the commonly used quality of life assessment tools and how to interpret their scores
| Tool | Components | Scoring and clusters | Overall score | Interpretation of results |
|---|---|---|---|---|
|
| ||||
| Reflux disease specific questionnaires | ||||
| QOLRAD | A total of 25 questions making up 5 dimensions | Each question is awarded a maximum score of 7 and patients are asked to rate the symptoms they have experienced over the preceding week on a 7-point scale | The total score for each domain is then calculated as an average of the total number of questions in each domain. The overall total score is the average of 25 questions | A higher score indicates better QoL |
| GERD-HRQL | A total of 10 items: 6 items measure satisfaction with degree of heartburn symptoms, two measure dysphagia or odynophagia and one assesses the impact of medication on daily life. The final item measures overall QoL | Each of the ten items is given a score out of 5, whereby 5 is for poor symptom control or satisfaction | The maximum score possible is 45. Composite responses are grouped as excellent (0-5), good (6-10), fair (11-15) and poor (15) | A higher score reflects worse patient symptoms and QoL |
|
| ||||
|
| ||||
|
| ||||
| GIQLI[ | A total of 36 items scored on a 5-point Likert scale[ | Score range can be between 0 and 144 | A maximum score of 144 | A higher score indicates better QoL[ |
| GSRS | A total of 15 items with 5 dimensions | Each question is rated on a 7-point scale | 1 represents absence of troublesome symptoms and 7 represents very troublesome symptoms | A higher score indicates poorer QoL |
|
| ||||
|
| ||||
|
| ||||
| SF-36 | A total of 36 items measured over 8 multi-item dimensions: PF, RP, BP, GH, VT, SF, RE and MH | All questions scored on a scale of 0-100, where 100 represents the highest level of functioning possible. A final score of each of the eight dimensions is obtained from averaging the scores | 0-100 | Norm-based scoring, where mean is standardised to 50. A score higher than 50 indicates better functioning and a score of 100 would indicate the highest possible level of functioning |
| SF-12[ | A total of 12 items and a practical version of SF-36. This uses the same eight domains as SF-36 | PCS and MCS scores calculated using the scores from the 12 questions | 0-100 | Norm-based scoring, where mean is standardised to 50. A score higher than 50 indicates better functioning and a score of 100 would indicate the highest possible level of functioning |
GERD-HRQL: Gastro-Oesophageal Reflux Disease-Health-Related Quality of Life, QOLRAD: Quality of Life in Reflux and Dyspepsia, QOL: Quality of life, GIQLI: Gastrointestinal Quality of Life Index, SF: Short Form health surveys, GSRS: Gastrointestinal Symptom Rating Scale, MCS: Mental component summary, PCS: Physical component summary, PF: Physical functioning, RP: Role-physical, BP: Bodily pain, GH: General health, VT: Vitality, SF: Social functioning, RE: Role-emotional, MH: Mental health, n/a: Not available
Pre- and post-operative quality of life improvement after giant hiatus hernia surgery, using a variety of questionnaires
| Authors | Total number of patients (number of patients followed up) | Length of follow-up (months) | Pre-operative score | Post-operative score | Improvement in QoL ( | Additional follow-up |
|---|---|---|---|---|---|---|
|
| ||||||
| GERD-HRQL | ||||||
| Stringham | 106 | 12 | 22.5 | 3 | Score 7 ( | |
| Asti | 84 (84) | 24 | 15.5 (MU), 18 (NM) | 1 (MU), 3 (NM) | n/a | |
| Shreshtha | 60 (60) | 60 | 27 (Veritas), 27 (Strattice) | 0 (Veritas), 0 (Strattice) | n/a | |
| Zahiri | 317 | 12 | 20.9 (initial), 21.1 (re-do) | 6.5 (initial), 8 (re-do) | n/a | |
| Zehetner | 35 (21) | 14 | n/a | 5 | 91.3% satisfied, 4.3% neutral, 4.3% dissatisfied | n/a |
| Parameswaran | 49 (31) | 19 | 18 | 1 | n/a | |
| Louie | 58 (55) | 15 | 14.7 | 7.6 | ||
| Merzilikin | 137 (59) | 60 | 11 | 5 | n/a | |
| Hall | 314 (188) | 24 | 14.4 | 6.6 | At 1 year - 5.7 ( | |
| Marano | 13 | 12 | 37.4 | 3.2 | n/a | |
| Siboni | 49 (37) | 24 | 11 | 2 | n/a | |
| Qureshi | 21 (14) | 13 | 22.9 | 6.9 | n/a | |
| Ilyashenko | 98 (69) | 48 | 17.5 (MU, | 3.8 (MU, | n/a | |
| Whitson | 61 (52) | 24 | n/a | 1.15 | Excellent 96.2%, Good 1.9% | n/a |
| Karmali | 93 (71) | 17 (LS) | n/a | n/a | Excellent result in 89% (LS) and 77% (OS) | n/a |
| Pierre | 203 | 18 | n/a | 2.4 | 84% Excellent, 8% good, 7% fair, 3% poor | n/a |
| Tam | 795 (606) | 25 | n/a | Good to Excellent QoL ( | n/a | |
|
| ||||||
|
| ||||||
|
| ||||||
| Louie | 58 (55) | 15 | 5 | 6 | ||
| Qureshi | 21 (14) | 13 | 4.09 | 6.04 | n/a | |
| Merzilikin | 137 (59) | 60 | 4 | 6.5 | n/a | |
| Hazebroek | 40 (37) | 12 | 3-4 | 5-6 | ||
| Hazebroek | 35 (30) | 43 | 3.98 | 6.04 | ||
| Stiven | 114 (94) | 12 | 3.7 | 5.5 | n/a | |
| Ng | 28 | 6 | 3.65§ | 5.29§ | n/a | n/a |
| Parker | 267 | 15.8 | 4.07 (mean) | 7 (mean) | n/a | |
|
| ||||||
|
| ||||||
|
| ||||||
| Chen | 69 (54) | 114 | n/a | 117 | Excellent or good in 83% | n/a |
| Dallemagne | 85 (64) | 118 | n/a | NRCR 114 | n/a | n/a |
| Targarona | 77 (37) | 108 | n/a | NR 127 | n/a | |
| Zhu | 30 (30) | 24 | 85.7 | 107.9 | n/a | |
| Zugel | 26 (20) | 12 (24 radiological) | 87 | 111 | NS (111) | n/a |
| Gibson | 100 (92) | 24 | 87.8 | 109.1 | n/a | |
| Furtado | 100 | 27 | 89 | 108 | n/a | |
|
| ||||||
|
| ||||||
|
| ||||||
| Tam | 795 (606) | 25 | n/a | Good to excellent QoL ( | n/a | |
| Koetje | 126 (91) | 24 | n/a | Improvement across all groups | PCS: | |
| Velanovich | 44 (39) | 24 | n/a | Quality of results not suitable to display | PCS ( | n/a |
|
| ||||||
|
| ||||||
|
| ||||||
| Parmeswaran | 49 (31) | 19 | Pain 3.67 | Pain 1.79 | n/a | |
*At 1 year, †at all post-operative time periods 5 weeks, 6 months, 12 months, ‡at all post-operative time periods 3 months, 6 months, 12 months, 18 months, 24 months, §Bougie, ¦No bougie. NS: Not significant at 3 months, MU: Mesh used, NM: No Mesh, NR: No recurrence, LS: Laparoscopic surgery, OS: Open surgery, CR-:Clinical recurrence; RR: Radiological recurrence, NRCR: Non-reinforced crural repair, RCR: Reinforced crural repair, GERD-HRQL: Gastro-Oesophageal Reflux Disease-Health-Related Quality of Life, QOLRAD: Quality of Life in Reflux and Dyspepsia, QOL: Quality of life, SF: Short Form health surveys, GIQLI: Gastrointestinal Quality of Life Index, GSRS: Gastrointestinal Symptom Rating Scale, n/a: Not available
Pre-operative and post-operative quality of life scores with focus on elderly patient demographics
| Authors | Total number of patients (number of patients followed up) | Mean age in years | Length of follow-up (months) | Mortality | Questionnaire used | Pre-operative score | Post-operative score | Improvement in QoL ( | |
|---|---|---|---|---|---|---|---|---|---|
| Louie | 58 (55) | 78§ | 15 | Nil | QOLRAD | 5* | 6* | ||
| Merzilikin | 137 (59) | 74 | 60 | 2 | QOLRAD | 4* | 6.5* | ||
| Hazebroek | 35 (30) | 76.6 | 43 | Nil | QOLRAD | 3.98 | 6.04 | ||
| Jalilvand | <80 | 162 | 62.8 | 1 | n/a | GERD-HRQL | 20‡ | 0‡ | No significant difference between groups ( |
| >80s | 23 | 85.3 | 22‡ | 0‡ | |||||
| Parker | <69 | 267 | 58 | 15.8 | n/a | QOLRAD | 4.2 | 7 | |
| 70-79 | 75 | 11.3 | 4 | 7 | |||||
| >80 | 83 | 11.3 | 4 | 7 | |||||
*QOLRAD, †GERD-HRQL, ‡GERSS, §median, ¦ at all post-operative time periods. GERSS: Gastro-Oesophageal Reflux Symptom Scale, GERD-HRQL: Gastro-Oesophageal Reflux Disease-Health-Related Quality of Life, QOLRAD: Quality of Life in Reflux and Dyspepsia, QOL: Quality of life, n/a: Not available
Impact of recurrence on post-operative quality of life scores
| Authors | Total number of patients (number of patients followed up) | Mean age (years) | Length of follow-up (months) | Recurrence rate (%) | Questionnaire used | QoL score (recurrence) | QoL score (without recurrence) | Impact of recurrence on QoL ( |
|---|---|---|---|---|---|---|---|---|
| Stringham | 106 | 68 | 12 | 18.8 | GERD-HRQL | 13 | 3.5 | SS |
| Louie | 58 (55) | 78 (median) | 15 | 10 | GERD-HRQL QOLRAD | 6.8*; 3.5† | 6.6*; 4† | NS |
| Tam | 795 (606) | n/a | 25 | 17-22 | GERD-HRQL | |||
| Targarona | 77 (37) | 64 | 108 | 46 | GIQLI | 110 | 122 | |
| Dallemagne | 85 (64) | 66 | 118 | 66 | GIQLI | 115 | 116 | |
| Chen | 69 (54) | 66 | 114 | 34 | GIQLI | 92 | 122 | |
| Gibson | 100 (92) | 69.1 | 24 | 9 | GIQLI | 110‡ | 94‡ | |
| Furtado | 100 | 71 | 27 | 24 | GIQLI; Visick; DSS | 108‡ | 106‡ | |
| Koetje | 126 (91) | n/a | 24 | 31 | SF-36 | 46.9¦; 48.8** | 51.2¦; 50.7** |
*QOLRAD, †GERD-HRQL, ‡GIQLI, §Good to excellent score, ¦SF-36 PCS, **SF-36 MCS. NS: Not statistically significant, no P provided, SS: Significantly improved post-operative QoL score in both groups compared to pre-operative scores and ‘higher QoL scores in patients without recurrence’, no P provided. GERD-HRQL: Gastro-Oesophageal Reflux Disease-Health-Related Quality of Life, SF: Short Form health surveys, MCS: Mental component summary, GIQLI: Gastrointestinal Quality of Life Index, QOL: Quality of life, QOLRAD: Quality of Life in Reflux and Dyspepsia, DSS: Dysphagia Severity Scale
Impact of using mesh compared with no mesh on quality of life outcomes
| Authors | Total number of patients (number followed up) | Mean age (years) | Length of follow-up (months) | Questionnaire used | Mesh type | Number of patients with mesh | Number of patients without mesh | Impact of mesh on post-operative QoL ( | ||
|---|---|---|---|---|---|---|---|---|---|---|
|
|
| |||||||||
| Pre-operative score | Post-operative score | Pre-operative score | Post-operative score | |||||||
| Asti | 84 (84) | 65 | 24 | GERD-HRQL | Pre-shaped biosynthetic (Gore Bio™) | 41 (15.5) | 2 | 43 (18) | 3 | |
| Ilyashenko | 98 (69) | 63 | 48 | GERD-HRQL | Non-absorbable self-fixating (ProGrip™) | 50 (17.5) | 3.8 | 48 (16.3) | 5.9 | |
| Wang | 55 | 65 | n/a | GERD-HRQL; | Porcine urinary bladder matrix | n/a | 32 (13.2*; 15†) | n/a | 33 (11.2*; 14†) | |
| Dallemagne | 85 (64) | 66 | 118 | GIQLI | Variable | n/a | 120 | n/a | 114 | |
| Koetje | 126 (91) | x | 24 | SF-36 | Absorbable (Surgisis; | n/a | 83 | n/a | 43 | Not significant |
| Oelschlager | 108 (72) | 64 | 58 | SF-36 | Biologic mesh Group (Surgisis) | n/a | 44‡ | n/a | 44‡ | |
*GERD-HRQL, †SF-36, ‡PCS, §MCS. GERD-HRQL: Gastro-Oesophageal Reflux Disease-Health-Related Quality of Life, SF: Short Form health surveys, PCS: Physical component summary, MCS: Mental component summary, GIQLI: Gastrointestinal Quality of Life Index, QOL: Quality of life, n/a: Not available
Impact of surgical technique on post-operative quality of life scores
| Authors | Total number of patients (number of patients followed up) | Mean age (years) | Length of follow-up (months) | Questionnaire used | Surgical technique compared (1); post- operative QoL score | Surgical technique compared (2); post-operative QoL score | Impact of surgical technique on QoL ( |
|---|---|---|---|---|---|---|---|
| Karmali | 93 (71) | 64 (L) | 17 (L) | GERD-HRQL | L 4 | O 4 | |
| Laan | 236 (193) | 71 | n/a | GERD-HRQL | N 83.7%§ | BM 88.4% | |
| Huerta | 179 (77) | 64 | 54 (N) | GERD-HRQL | N 2 | T 4 | |
| Ferri | 60 (57) | n/a | 45 | GERD-HRQL; SF-12 | L 4* | O 1* | |
| Ng | 28 | B 70.83 | 6 | QOLRAD | B 5.3 | NB 6.3 |
*GERD HRQL score, †SF-12 PCS score, ‡SF-12 MCS score §excellent or good results. L: Laparoscopic, O: Open, N: Nissen, T: Toupet, BM: Belsey Mark, B: Bougie, NB: No Bougie, GERD-HRQL: Gastro-Oesophageal Reflux Disease-Health-Related Quality of Life, QOLRAD: Quality of Life in Reflux and Dyspepsia, QOL: Quality of life, SF: Short Form health surveys, MCS: Mental component summary
Impact of Collis gastroplasty on quality of life outcomes
| Authors | Total number of patients (number of patients followed up) | Mean age (years) | Length of follow-up (months) | Mortality (absolute number) | Recurrence (percentage of patients) | Questionnaire used | Pre-operative Score | Post-operative score (%) | Improvement in QOL ( |
|---|---|---|---|---|---|---|---|---|---|
| Stringham | 106 | 68 | 12 | 1 | 18.8 | GERD-HRQL | 22.5 | 3 | |
| Karmali | 93 (71) | L 64 | 17 (L) | 0 | 9 | GERD-HRQL | n/a | L 89‡ | n/a |
| Pierre | 203 | 67 | 18 | 1 | 9.3 | GERD-HRQL | n/a | 2.4 | n/a |
| Whitson | 61 (52) | 61.9 | 24 | 1 | 4.7 | GERD-HRQL | n/a | 1.15 | n/a |
| Merzilikin | 137 (59) | 74 | 60 | 23 | 8.4 | QOLRAD | 4† | 6.5† | |
| Nason | 795 (606) | 392 (<70) | n/a | 14 | 18.2 | GERD-HRQL | n/a | 88‡,§ | n/a |
| Velanovich | 44 (39) | 66.1 | 24 | 1 | 7.6 | SF-36 | n/a | n/a | PF ( |
*GERDHRQL, †QOLRAD, ‡patients had excellent results, §patients had good results. PF: Physical functioning component of PCS score, L: Laparoscopic, O: Open, GERD-HRQL: Gastro-Oesophageal Reflux Disease-Health-Related Quality of Life, QOLRAD: Quality of Life in Reflux and Dyspepsia, QOL: Quality of life, SF: Short Form health surveys, PCS: Physical component summary